| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0026 | 1 |